VERX
Vertex Inc - Ordinary Shares Class A

426
Mkt Cap
$3.08B
Volume
2.00
52W High
$60.71
52W Low
$18.54
PE Ratio
-55.22
VERX Fundamentals
Price
$19.00
Prev Close
$19.30
Open
$19.04
50D MA
$19.76
Beta
0.84
Avg. Volume
1.27M
EPS (Annual)
-$0.3395
P/B
11.46
Rev/Employee
$350,934.74
Loading...
Loading...
News
all
press releases
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Bailard Inc.
Bailard Inc. trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 9.2% during the 3rd quarter, according to the company in its most recent 13F filing...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Best Biotech Stocks To Add to Your Watchlist - January 20th
ImmunityBio, Danaher, Moderna, argenex, Vertex Pharmaceuticals, Abivax, and Recursion Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·16h ago
News Placeholder
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA cut its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 60.8% in the third quarter, according to the company in its most recent...
MarketBeat·22h ago
News Placeholder
Vertex, Inc. (NASDAQ:VERX) Receives Consensus Rating of "Moderate Buy" from Brokerages
Shares of Vertex, Inc. (NASDAQ:VERX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seventeen analysts that are covering the firm, Marketbeat.com reports. One...
MarketBeat·1d ago
News Placeholder
Americana Partners LLC Buys 12,134 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Americana Partners LLC increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 98.4% during the third quarter, according to its most recent filing with...
MarketBeat·1d ago
News Placeholder
Allstate Corp Makes New $3.64 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX
Allstate Corp purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange...
MarketBeat·1d ago
News Placeholder
Biotech Stocks To Research - January 19th
ImmunityBio, Danaher, Vertex Pharmaceuticals, Moderna, argenex, United Therapeutics, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·2d ago
News Placeholder
Vertex, Inc. (NASDAQ:VERX) Short Interest Up 20.6% in December
Vertex, Inc. (NASDAQ:VERX - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling 7,266,393...
MarketBeat·2d ago
News Placeholder
Biotech Stocks Worth Watching - January 18th
ImmunityBio, Danaher, Vertex Pharmaceuticals, Moderna, argenex, United Therapeutics, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·3d ago
News Placeholder
Nippon Life Global Investors Americas Inc. Makes New $1.11 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX
Nippon Life Global Investors Americas Inc. bought a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the third quarter, according to the company in its...
MarketBeat·3d ago
<
1
2
...
>

Latest VERX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.